Each year, The CHEST Foundation offers grant opportunities for clinical and translational research, leadership, and volunteer community service. In 2014, grants are offered in thrombosis, lung cancer, pulmonary arterial hypertension, COPD and alpha-1 antitrypsin deficiency, women’s lung health, pulmonary fibrosis, and community service. To learn more about these and the other awards, or to apply by the May 31, 2014, deadline, go to the Foundation’s grants and awards webpage: chestnet.org/Foundation/What-We-Do/Apply-for-a-Grant.
• The GlaxoSmithKline Distinguished Scholar in Thrombosis award is supported for $150,000 over 3 years.
• The CHEST Foundation and the Pulmonary Fibrosis Foundation Clinical Research Grant in Pulmonary Fibrosis is supported in part by InterMune, for $30,000 for 1 year.
• The CHEST Diversity Committee Young Investigator in Pulmonary, Cardiovascular, Critical Care, or Sleep Research Grant is supported in part by AstraZeneca, for $25,000 for 1 year.
• The CHEST Foundation and Respiratory Health Association Clinical Research Grant in Women’s Lung Health is supported in part by AstraZeneca, for $10,000 for 1 year.
• The Clinical Research Grant in Pulmonary Arterial Hypertension is supported by Actelion, for $50,000 for 1 year.
• The CHEST Foundation and the Alpha-1 Foundation Clinical Research Grant in COPD and Alpha-1 Antitrypsin (AAT) Deficiency is supported for $25,000 for 1 year.
• The Clinical Research Grant in Lung Cancer is supported by Genentech, for $100,000 over 2 years.
• The Community Service Grants Honoring D. Robert McCaffree, MD, Master FCCP, Award range from $5,000 to $15,000 for 1 year.